StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Prabhudas Lilladher

BUYMax Healthcare Institute Limited
Max Healthcare Institute share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1 year)14 Aug 2025via Institutional / Brokerage Research

Entry₹1,220.7Inferred
Target₹1,355
Total upside +11.00% (call closed)
Stop lossNot given
At expiry₹1,008.614 Aug 2026, 3:30 pm
Expired-17.38%auction close
Follow Prabhudas Lilladher for new calls(70% target hit, 407 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 19 active Long-term calls on MAXHEALTHSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026
18 supporting6 neutral2 opposing
Supports the BUY call (18)

7 other SEBI-registered advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · same horizon·14 Aug · today

Max Healthcare Q1 results: Revenue, EBITDA rise 15% each; Margins at 24.8%

NewsCnbc-Tv18·13 Aug · yesterday

(opens in new tab)

Max Healthcare reported Q1 revenue of Rs. 2,982 Cr, a 16% YoY increase. Network Operating EBITDA grew 15% YoY to Rs. 704 Cr, and Q1 PAT was Rs. 357 Cr.

BSE · Company Update·13 Aug · yesterday

(opens in new tab)

Max Healthcare Profit Rises 34% To ₹1,442 Crore In FY26

NewsGoogle News·30 Jul · 2w ago

(opens in new tab)

Max Healthcare Share: 2% உயர்வு! வளர்ச்சி அவுட்லுக் வலுவாக உள்ளதா?

NewsGoogle News·27 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (6)

Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·13 Aug · yesterday

(opens in new tab)

Max Healthcare Institute Limited disclosed an update on ongoing litigation concerning its subsidiary, Kalinga Hospital Ltd. The National Company Law Tribunal (NCLT) permitted the opposing party to rec

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·7 Aug · 6d ago

(opens in new tab)

Max Healthcare Institute Limited disclosed an update on petitions filed before the National Company Law Tribunal concerning Kalinga Hospital Ltd. The matter has been adjourned to August 4, 2026.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·24 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (2)

1 other SEBI-registered advisor has an active long-term SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·14 Aug · today

HDFC Life Falls 1.8% Despite 12% Profit Rise in Q1 FY27

NewsGoogle News·16 Jul · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Max Healthcare Institute

All analyst calls on Max Healthcare Institute

More from Prabhudas Lilladher

Every call and its outcome